Market Access Cases Cases > Market Access How we’ve helped other companies launch their products Browse the articles below to see how we helped other pharmaceutical companies get faster market access for their products in Denmark and the Nordics. If you’re interested in a different service area, visit our curated collection of cases within Real-World Evidence, Advanced Market Research, and Sales Performance. Launching companion diagnostics in the Nordics Market Access Reimbursement strategies HTA processes Inspire me Nordic market access strategy enhanced by RWE Market Access Launch Acceleration Patient copayment strategies Inspire me Securing gene therapy market access in Denmark Market Access Reimbursement strategies Rare genetic disease Inspire me Securing vaccine market access in the Nordics Market Access Regulatory compliance Funding mechanisms Inspire me About Signum Signum empowers life science companies to make data-driven decisions that grow their business and create human impact. Relying on their exclusive access to pharmaceutical sales data and to the Danish Health Data Authority’s Secure Research Platform (“Forskermaskinen”), Signum’s team of 50+ specialists and consultants delivers actionable insights across Real-World Evidence, Market Access, Advanced Market Research, Sales Performance, and omnichannel HCP engagement. Proudly part of the Lif group (the Danish Association of the Pharmaceutical Industry), Signum has been driving success pre- and post-launch for nearly 50 years. Get in touch Leave a message and we will get back to you ASAP. We process your personal information in accordance with our Privacy Policy. First Name: Last Name: Company: E-mail: Your Message:
